Published in Biochem J on February 15, 2006
Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal (2012) 2.13
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells. Cancer Res (2010) 1.65
Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease. Mediators Inflamm (2016) 1.39
Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity. ChemMedChem (2011) 0.95
Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis. Br J Cancer (2007) 0.89
Expression of alkaline sphingomyelinase in yeast cells and anti-inflammatory effects of the expressed enzyme in a rat colitis model. Dig Dis Sci (2008) 0.85
Hits of a high-throughput screen identify the hydrophobic pocket of autotaxin/lysophospholipase D as an inhibitory surface. Mol Pharmacol (2013) 0.82
Molecular modeling of human alkaline sphingomyelinase. Bioinformation (2011) 0.78
Clinical Evidence for the Microbiome in Inflammatory Diseases. Front Immunol (2017) 0.75
Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join Forces. Mediators Inflamm (2016) 0.75
Computational identification and experimental characterization of substrate binding determinants of nucleotide pyrophosphatase/phosphodiesterase 7. BMC Biochem (2011) 0.75
Potential immunosuppressive effects of Escherichia coli O157:H7 experimental infection on the bovine host. BMC Genomics (2016) 0.75
Changes of activity and isoforms of alkaline sphingomyelinase (nucleotide pyrophosphatase phosphodiesterase 7) in bile from patients undergoing endoscopic retrograde cholangiopancreatography. BMC Gastroenterol (2014) 0.75
Platelet-activating factor and related lipid mediators. Annu Rev Biochem (2000) 3.44
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest (1986) 2.90
Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest (1988) 2.23
Platelet-activating factor: receptors and signal transduction. Biochem J (1993) 2.12
Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases. J Biol Chem (2001) 1.67
Site-directed mutagenesis using a double-stranded DNA fragment as a PCR primer. Nucleic Acids Res (1990) 1.54
Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family. J Biol Chem (2003) 1.28
Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. Gastroenterology (1987) 1.24
The presence of spingomyelin- and ceramide-cleaving enzymes in the small intestinal tract. Biochim Biophys Acta (1969) 1.23
H2O2 and tumor necrosis factor-alpha induce differential binding of the redox-responsive transcription factors AP-1 and NF-kappaB to the interleukin-8 promoter in endothelial and epithelial cells. J Biol Chem (1998) 1.23
Platelet-activating factor receptor: gene expression and signal transduction. Biochim Biophys Acta (1995) 1.22
Role of cytokines and platelet-activating factor in inflammatory bowel disease. Implications for therapy. Dis Colon Rectum (1996) 1.17
Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes. Immunology (1991) 1.16
Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C. J Biol Chem (1999) 1.12
Plasma platelet activating factor-acetylhydrolase (PAF-AH). Prog Lipid Res (2003) 1.11
Platelet-activating factor and liver metastasis of colorectal cancer. Int J Cancer (2005) 1.08
Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2. Biochem J (2004) 1.08
Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Cancer (1997) 1.07
Intestinal epithelial cells contribute to the enhanced generation of platelet activating factor in ulcerative colitis. Gut (1993) 1.07
Intestinal NF-kappaB is activated, mainly as p50 homodimers, by platelet-activating factor. Biochim Biophys Acta (1998) 1.05
Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis. Cancer Res (2002) 1.04
Cholecystokinin rapidly activates mitogen-activated protein kinase in rat pancreatic acini. Am J Physiol (1994) 1.02
Tissue concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes' stage of patients. Oncogene (2003) 1.02
Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis. Gut (2004) 1.02
Alkaline sphingomyelinase activity in rat gastrointestinal tract: distribution and characteristics. Biochim Biophys Acta (1995) 0.98
Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity. Inflamm Bowel Dis (2002) 0.97
Electrospray ionization for analysis of platelet-activating factor. Rapid Commun Mass Spectrom (1991) 0.97
Role of platelet activating factor in the intestinal epithelial secretory and Chinese hamster ovary cell cytoskeletal responses to cholera toxin. Proc Natl Acad Sci U S A (1994) 0.96
Pancreatic trypsin cleaves intestinal alkaline sphingomyelinase from mucosa and enhances the sphingomyelinase activity. Am J Physiol Gastrointest Liver Physiol (2004) 0.95
Sphingolipid hydrolyzing enzymes in the gastrointestinal tract. Methods Enzymol (2000) 0.95
Purification, localization, and expression of human intestinal alkaline sphingomyelinase. J Lipid Res (2003) 0.94
Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells. Carcinogenesis (2004) 0.94
Identification of an alkaline sphingomyelinase activity in human bile. Biochim Biophys Acta (1996) 0.93
Detection of alkaline sphingomyelinase activity in human stool: proposed role as a new diagnostic and prognostic marker of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2005) 0.91
Functional studies of human intestinal alkaline sphingomyelinase by deglycosylation and mutagenesis. Biochem J (2005) 0.89
Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: a key factor to the unrestrained cell proliferation? Br J Cancer (1999) 0.89
Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin. Liver (2002) 0.88
Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro. Br J Pharmacol (1998) 0.85
Platelet activating factor in stool from patients with ulcerative colitis and Crohn's disease. Hepatogastroenterology (1999) 0.85
Purification of a newly identified alkaline sphingomyelinase in human bile and effects of bile salts and phosphatidylcholine on enzyme activity. Hepatology (1997) 0.84
Thromboxane A(2)-mediated Cl(-) secretion induced by platelet-activating factor in isolated rat colon. Eur J Pharmacol (2000) 0.84
Purification, characterization, and expression of rat intestinal alkaline sphingomyelinase. J Lipid Res (2002) 0.82
Human eosinophils migrate across an intestinal epithelium in response to platelet-activating factor. Gastroenterology (1995) 0.82
Role of platelet-activating factor in the pathophysiology of necrotizing enterocolitis. Acta Paediatr Suppl (2002) 0.80
Evidence for a colonic PAF receptor. J Surg Res (1995) 0.78
Catabolism of platelet-activating factor by human colonic mucosa. Calcium dependence of the catabolizing enzymes. Biochem Pharmacol (1992) 0.77
PAF and the digestive tract. A review. J Pharm Pharmacol (1996) 0.76
Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med (2003) 3.74
Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem (2005) 1.88
Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. J Biol Chem (2005) 1.39
Absorption and lipoprotein transport of sphingomyelin. J Lipid Res (2005) 1.38
Serum levels of 2,2',4,4',5,5'-hexachlorobiphenyl (CB-153) in relation to markers of reproductive function in young males from the general Swedish population. Environ Health Perspect (2003) 1.33
Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family. J Biol Chem (2003) 1.28
TRPV1 in brain is involved in acetaminophen-induced antinociception. PLoS One (2010) 1.25
Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlations with antioxidant levels. J Agric Food Chem (2004) 1.23
Functional characterization of the CCL25 promoter in small intestinal epithelial cells suggests a regulatory role for caudal-related homeobox (Cdx) transcription factors. J Immunol (2006) 1.21
Phosphatidylethanol in human organs and blood: a study on autopsy material and influences by storage conditions. Alcohol Clin Exp Res (2004) 1.21
Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells. Carcinogenesis (2002) 1.20
Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T cells. J Immunol (2009) 1.17
Fertility and markers of male reproductive function in Inuit and European populations spanning large contrasts in blood levels of persistent organochlorines. Environ Health Perspect (2008) 1.13
Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development. Prog Lipid Res (2008) 1.11
Hydroxy-PCBs, PBDEs, and HBCDDs in serum from an elderly population of Swedish fishermen's wives and associations with bone density. Environ Sci Technol (2006) 1.05
Phthalates and perfluorooctanesulfonic acid in human amniotic fluid: temporal trends and timing of amniocentesis in pregnancy. Environ Health Perspect (2012) 1.04
Association between pregnancy loss and urinary phthalate levels around the time of conception. Environ Health Perspect (2011) 1.03
Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets. Mol Immunol (2008) 1.03
Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study. BMC Cancer (2011) 1.03
Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway. Int J Mol Med (2002) 1.01
Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation. Br J Pharmacol (2005) 1.00
Prenatal phthalate exposures and anogenital distance in Swedish boys. Environ Health Perspect (2014) 0.99
Lead, mercury, and cadmium in blood and their relation to diet among Swedish adults. Food Chem Toxicol (2013) 0.99
Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity. Inflamm Bowel Dis (2002) 0.97
Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-kappaB in macrophages. Inflamm Res (2009) 0.96
Pancreatic trypsin cleaves intestinal alkaline sphingomyelinase from mucosa and enhances the sphingomyelinase activity. Am J Physiol Gastrointest Liver Physiol (2004) 0.95
LY294002 enhances boswellic acid-induced apoptosis in colon cancer cells. Anticancer Res (2009) 0.94
Effects of diesel exposure on lung function and inflammation biomarkers from airway and peripheral blood of healthy volunteers in a chamber study. Part Fibre Toxicol (2013) 0.94
Purification, localization, and expression of human intestinal alkaline sphingomyelinase. J Lipid Res (2003) 0.94
Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells. Carcinogenesis (2004) 0.94
Impact of PCB and p,p'-DDE contaminants on human sperm Y:X chromosome ratio: studies in three European populations and the Inuit population in Greenland. Environ Health Perspect (2006) 0.94
Blood serum concentrations of perfluorinated compounds in men from Greenlandic Inuit and European populations. Chemosphere (2012) 0.93
On the adhesion between fine particles and nanocontacts: an atomic force microscope study. Langmuir (2006) 0.93
Ursolic acid inhibits proliferation and stimulates apoptosis in HT29 cells following activation of alkaline sphingomyelinase. Anticancer Res (2003) 0.92
Sperm DNA integrity in relation to exposure to environmental perfluoroalkyl substances - a study of spouses of pregnant women in three geographical regions. Reprod Toxicol (2012) 0.92
Prenatal Phthalate, Perfluoroalkyl Acid, and Organochlorine Exposures and Term Birth Weight in Three Birth Cohorts: Multi-Pollutant Models Based on Elastic Net Regression. Environ Health Perspect (2015) 0.91
Arachidonic acid and ischemic heart disease. J Nutr (2005) 0.91
Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression. Lipids Health Dis (2010) 0.91
Determinants of maternal and fetal exposure and temporal trends of perfluorinated compounds. Environ Sci Pollut Res Int (2013) 0.91
Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces. J Environ Monit (2004) 0.91
Comparison of the 2,2'-azinobis-3-ethylbenzotiazo-line-6-sulfonic acid (ABTS) and ferric reducing anti-oxidant power (FRAP) methods to asses the total antioxidant capacity in extracts of fruit and vegetables. Mol Nutr Food Res (2005) 0.90
Purification and characterization of human intestinal neutral ceramidase. Biochimie (2007) 0.89
Functional studies of human intestinal alkaline sphingomyelinase by deglycosylation and mutagenesis. Biochem J (2005) 0.89
Crucial role of alkaline sphingomyelinase in sphingomyelin digestion: a study on enzyme knockout mice. J Lipid Res (2010) 0.89
CD14(hi)HLA-DR(dim) macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohn's disease. J Leukoc Biol (2013) 0.89
Polycyclic aromatic hydrocarbon exposure, urinary mutagenicity, and DNA adducts in rubber manufacturing workers. Cancer Epidemiol Biomarkers Prev (2008) 0.88
Magnetic nanohydroxyapatite/PVA composite hydrogels for promoted osteoblast adhesion and proliferation. Colloids Surf B Biointerfaces (2012) 0.87
Purified intestinal alkaline sphingomyelinase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cells. J Cancer Res Clin Oncol (2003) 0.87
Degree of in vivo inhibition of human gastric and pancreatic lipases by Orlistat (Tetrahydrolipstatin, THL) in the stomach and small intestine. Clin Nutr (2002) 0.87
Trans-resveratrol attenuates high fatty acid-induced P2X7 receptor expression and IL-6 release in PC12 cells: possible role of P38 MAPK pathway. Inflammation (2015) 0.86
Monoacylglycerols activate TRPV1--a link between phospholipase C and TRPV1. PLoS One (2013) 0.86
Xenoandrogenic activity in serum differs across European and Inuit populations. Environ Health Perspect (2007) 0.86
Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats. J Cancer Res Clin Oncol (2007) 0.86
Curcumin decreases acid sphingomyelinase activity in colon cancer Caco-2 cells. Planta Med (2007) 0.86
Determination of isocyanates in air using 1-(2-methoxyphenyl)piperazine-impregnated filters: long-term sampling performance and field comparison with impingers with dibutylamine. Ann Occup Hyg (2004) 0.86
Long term effects on human plasma lipoproteins of a formulation enriched in butter milk polar lipid. Lipids Health Dis (2009) 0.86
Biological monitoring of exposure to toluene diisocyanate. Scand J Work Environ Health (2004) 0.86
Expression of alkaline sphingomyelinase in yeast cells and anti-inflammatory effects of the expressed enzyme in a rat colitis model. Dig Dis Sci (2008) 0.85
Levels of 2-thiothiazolidine-4-carboxylic acid (TTCA) and effect modification of polymorphisms of glutathione-related genes in vulcanization workers in the southern Sweden rubber industries. Int Arch Occup Environ Health (2007) 0.85
Understanding the molecular activity of alkaline sphingomyelinase (NPP7) by computer modeling. Biochemistry (2010) 0.84
Association between exposure to persistent organohalogen pollutants and epididymal and accessory sex gland function: multicentre study in Inuit and European populations. Reprod Toxicol (2006) 0.84
Differences in serum levels of CB-153 and p,p'-DDE, and reproductive parameters between men living south and north in Norway. Reprod Toxicol (2011) 0.84
Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition. Eur J Heart Fail (2006) 0.84
Upper reference limits for biomarkers of exposure to aromatic diisocyanates. Int Arch Occup Environ Health (2005) 0.84
Generating ceramide from sphingomyelin by alkaline sphingomyelinase in the gut enhances sphingomyelin-induced inhibition of cholesterol uptake in Caco-2 cells. Dig Dis Sci (2010) 0.84
Effects of sample preparation on bacterial colonization of polymers. Langmuir (2010) 0.84
A nested case-control study of intrauterine exposure to persistent organochlorine pollutants and the risk of hypospadias. PLoS One (2012) 0.83
Effects of filler type and content on mechanical properties of photopolymerizable composites measured across two-dimensional combinatorial arrays. Acta Biomater (2009) 0.83
Sphingolipids in human ileostomy content after meals containing milk sphingomyelin. Am J Clin Nutr (2010) 0.83
Amniotic fluid phthalate levels and male fetal gonad function. Epidemiology (2015) 0.83
Quantitative role of plasma free fatty acids in the supply of arachidonic acid to extrahepatic tissues in rats. J Nutr (2002) 0.83
Anthropometry in 5- to 9-Year-Old Greenlandic and Ukrainian Children in Relation to Prenatal Exposure to Perfluorinated Alkyl Substances. Environ Health Perspect (2015) 0.82
Purification, characterization, and expression of rat intestinal alkaline sphingomyelinase. J Lipid Res (2002) 0.82
The SELMA study: a birth cohort study in Sweden following more than 2000 mother-child pairs. Paediatr Perinat Epidemiol (2012) 0.82
In vivo conjugation of nasal lavage proteins by hexahydrophthalic anhydride. Toxicol Appl Pharmacol (2004) 0.82